Eterna Therapeutics (NASDAQ:ERNA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Eterna Therapeutics (ERNA) operate in?

Eterna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Eterna Therapeutics Stock (NASDAQ: ERNA) stock price, news, charts, stock research, profile.

Open	$0.24
Close	$0.25
Volume / Avg.	425.23K / 700.65K
Day Range	$0.24 - $0.26
52 Wk Range	0.22 - 2.63
Market Cap	$12.60M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	22
Short Interest	0.23%
Days to Cover	1

Recent News

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.24
Close	$0.25
Volume / Avg.	425.23K / 700.65K
Day Range	$0.24 - $0.26
52 Wk Range	0.22 - 2.63
Market Cap	$12.60M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	22
Short Interest	0.23%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Eterna Therapeutics (ERNA) stock?

You can purchase shares of Eterna Therapeutics (NASDAQ:ERNA) through any online brokerage.

View our list of the best stock brokerages

Who are Eterna Therapeutics (ERNA) competitors?

Other companies in Eterna Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Imunon (NASDAQ:IMNN), Sensei Biotherapeutics (NASDAQ:SNSE) and GlycoMimetics (NASDAQ:GLYC).

What is the forecast, or price target, for Eterna Therapeutics (ERNA) stock?

There is no analysis for Eterna Therapeutics to provide a consensus price target.

What is the current price for Eterna Therapeutics (ERNA)?

The stock price for Eterna Therapeutics (NASDAQ: ERNA) is $0.2452 last updated December 20, 2024 at 7:50 PM EST.

Does Eterna Therapeutics (ERNA) pay a dividend?

There are no upcoming dividends for Eterna Therapeutics.

When is Eterna Therapeutics (NASDAQ:ERNA) reporting earnings?

Eterna Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.

Is Eterna Therapeutics (ERNA) going to split?

There is no upcoming split for Eterna Therapeutics.

What sector and industry does Eterna Therapeutics (ERNA) operate in?

Eterna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Eterna Therapeutics

Eterna Therapeutics (ERNA) Forecast